In the first trial of its kind, Austrian researchers have achieved success with an allergy vaccine using genetically engineered pollen.The findings are reported in this week’s issue of the Proceedings of the National Academy of Sciences.
In the first trial of its kind, Austrian researchers have achieved success with an allergy vaccine using genetically engineered pollen.The findings are reported in this week’s issue of the Proceedings of the National Academy of Sciences.
